The obesity epidemic is contributing substantially to the burden of cardiovascular disease including heart disease and congestive heart failure, in the United States and the rest of the world. Overnutrition as a driver of obesity, promotes alterations in fatty acid, lipid, and glucose metabolism that influence myocardial function and progression of heart failure from diastolic to systolic failure. The association of progressive heart failure and progressive chronic kidney disease is well documented and often referred to as the cardiorenal syndrome, as well as a prognosticator for cerebrovascular disease (e.g. stroke). Whether the relationship between obesity, heart disease/failure and risk for chronic kidney disease and stroke is direct or a confluence of risk factors is poorly understood.
James R. Sowers, MD
Diabetes and Cardiovascular Center of Excellence
Columbia School of Medicine, University of Missouri
One Hospital Drive, Columbia, MO 65212 (USA)
Published online: May 03, 2013
Number of Print Pages : 9
Number of Figures : 1, Number of Tables : 0, Number of References : 38
Book Serie: Contributions to Nephrology, Vol. 179, Year 2013
Editor(s): Toyoda, K. (Osaka)
ISSN: 0302-5144 (Print), eISSN: 1662-2782 (Online)
For additional information:
Book Title: Brain, Stroke and Kidney
Editor(s): Toyoda K (ed)
For additional information:
Article / Publication Details
Published online: 5/3/2013
Cover Date: 2013
Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 0
ISBN: 978-3-318-02351-0 (Print)
eISBN: 978-3-318-02352-7 (Online)
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.